Video

Dr. Choti on Future Treatment of Patients With Stage IV Pancreatic Cancer

Michael A. Choti, MD, discusses the future of treatment for patients with stage IV pancreatic cancer.

Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the future of treatment for patients with stage IV pancreatic cancer.

There are novel agents and new forms of chemotherapy in development for patients with inoperable, stage IV pancreatic cancer, says Choti. The strategy for these patients are to find effective therapies for which chemotherapy is applied in neoadjuvant or potentially curative situations.

The most common regimen is a combination of aggressive cytotoxic chemotherapy to offer in a neoadjuvant setting patients who are potentially operable. A common form of chemotherapy is a combination of fluorouracil, leucovorin, irinotecan, and oxaliplatincalled FOLFIRINOX. Another common regimen is the combination of gemcitabine and nab-paclitaxel (Abraxane), which is typically used in a neoadjuvant setting for patients with pancreatic cancer who are resectable or borderline resectable.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity